VP, Insights Sales (Brio

WE ARE RARE

Bionews is a digital health solutions company dedicated to empowering more than 50 rare disease communities with trusted information, news, and connections. We foster a space where hope thrives, and patients' voices are heard. Since 2013, we've been committed to serving patients and elevating their voices. Our motto is “For Rare, By Rare.” With over 50% of our team living with or caring for someone with a rare condition, we deeply understand the unique challenges and needs of these communities.

Our network of more than 500,000 registered members actively seeks news, clinical insights, and shared experiences, creating a safe space for peer support, connection, and learning.

Bionews is diversifying beyond its core Digital DTC business into HCP, Insights, Clinical Recruitment, and direct pharma partnerships, and Insights is central to that growth. The VP, Insights Sales is a full-time, quota-carrying seller responsible for building and closing new business across Bionews' Insights portfolio, with a primary focus on launching and selling Brio, Bionews' new subscription-based rare disease market research platform, to pharma and biotech clients.

Brio is the first patient research platform built inside real rare disease communities: consented, proprietary, and covering 16 conditions at launch in fall 2026. This role will own the go-to-market motion for Brio as a net-new subscription product, while also selling Bionews' broader Insights capabilities (custom research, patient advisory panels, surveys, and syndicated data) to medical affairs, market research, insights, and brand teams at pharma and biotech companies.

This is a strategic, high-visibility hire reporting into Commercial Leadership, with significant influence over how Bionews positions and prices a brand-new product line in market.

This role is designed to lead Insights and Brio new-business sales as the function scales alongside the company's evolving needs and strategic priorities. Brio launches in fall 2026; the initial months of this role will center on pipeline-building, early-adopter sales, and refining positioning and pricing in partnership with Product and Marketing, with quota and territory scope expanding as the platform matures.

• Go-to-Market Ownership: identify and prioritize target accounts across pharma and biotech medical affairs, market research/insights, and brand teams for the fall 2026 launch.

• Demo & Consultative Selling: run discovery calls, platform demos, and proposal development to convert prospects into Brio subscribers across the 16 launch conditions.

• Client Acquisition: close new subscription agreements and manage the full sales cycle from first outreach through contract signature and onboarding handoff.

• Pricing & Packaging Feedback: partner with the Insights/Brio product team on packaging, pricing, and positioning based on live market feedback.

• Portfolio Cross-Sell: sell Bionews' broader Insights offerings, including custom market research, patient advisory panels, surveys, and syndicated data, to complement Brio and expand wallet share within accounts.

• Pipeline Development: build and maintain a qualified pipeline sufficient to meet quarterly and annual revenue targets for the Insights line of business.

• Cross-Functional Bundling: identify opportunities to bundle Insights/Brio into broader Bionews pharma partnerships alongside DTC, HCP, and Clinical Recruitment.

• Salesforce Discipline: maintain accurate, current Salesforce records for all opportunities, activities, and forecasts.

• Forecast Accuracy: provide reliable weekly and monthly forecasts to Commercial Leadership, flagging risk and acceleration opportunities early.

• Account Ownership: serve as the primary point of contact for Brio and Insights clients from first conversation through renewal, ensuring a strong client experience that supports retention and expansion.

• Patient-Centered Selling: bring the patient voice into every pitch. Bionews' key differentiator is the ability to bring real…